ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,320.12
-0.02%
Dow Jones
39,864.97
-0.02%
US Dollar vs MXN
16.6661
0.27%
Brent Oil
81.70
-0.90%
Bitcoin
69,834.20
-0.42%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Genetic Technologies Ltd (GENE)

  7. Genetic Technologies Ltd (GENE) Noticias

GENE

Genetic Technologies (GENE)

Genetic Technologies Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GENE
FechaHoraFuenteTítuloSímboloCompañía
06/05/202407:00GlobeNewswire Inc.GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employeesNASDAQ:GENEGenetic Technologies Ltd
22/04/202414:00GlobeNewswire Inc.Genetic Technologies Announces Closing of US$2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
18/04/202411:17GlobeNewswire Inc.Genetic Technologies Announces $2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
17/04/202407:00GlobeNewswire Inc.New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment OutcomesNASDAQ:GENEGenetic Technologies Ltd
16/04/202407:00GlobeNewswire Inc.GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on YearNASDAQ:GENEGenetic Technologies Ltd
11/04/202407:00GlobeNewswire Inc.GTG to pilot GeneType in Breast Screen centers across the U.S.NASDAQ:GENEGenetic Technologies Ltd
08/04/202407:00GlobeNewswire Inc.EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”NASDAQ:GENEGenetic Technologies Ltd
02/04/202407:05GlobeNewswire Inc.Genetic Technologies’ Digital Strategy Ignites Significant Traction in US MarketNASDAQ:GENEGenetic Technologies Ltd
26/03/202407:00GlobeNewswire Inc.GTG Global Collaborations and Innovation UpdateNASDAQ:GENEGenetic Technologies Ltd
25/03/202407:00GlobeNewswire Inc.GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised HealthcareNASDAQ:GENEGenetic Technologies Ltd
26/02/202407:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
14/02/202413:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GENEGenetic Technologies Ltd
31/01/202407:00GlobeNewswire Inc.Launching our most comprehensive test and expanding into new global marketsNASDAQ:GENEGenetic Technologies Ltd
05/01/202407:00GlobeNewswire Inc.Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:GENEGenetic Technologies Ltd
04/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GENEGenetic Technologies Ltd
20/12/202316:00Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:GENEGenetic Technologies Ltd
14/12/202307:00GlobeNewswire Inc.GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized WellnessNASDAQ:GENEGenetic Technologies Ltd
12/12/202307:00GlobeNewswire Inc.Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio ChangeNASDAQ:GENEGenetic Technologies Ltd
30/10/202307:00GlobeNewswire Inc.Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical TrialNASDAQ:GENEGenetic Technologies Ltd
18/10/202307:30GlobeNewswire Inc.GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and TreatmentNASDAQ:GENEGenetic Technologies Ltd
27/09/202308:00GlobeNewswire Inc.GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital NetworkNASDAQ:GENEGenetic Technologies Ltd
12/09/202307:00GlobeNewswire Inc.Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian ReleaseNASDAQ:GENEGenetic Technologies Ltd
11/09/202307:30GlobeNewswire Inc.GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry PartnerNASDAQ:GENEGenetic Technologies Ltd
01/09/202309:00GlobeNewswire Inc.Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TVNASDAQ:GENEGenetic Technologies Ltd
30/08/202307:45GlobeNewswire Inc.Annual Results – Momentum Building on our Commercial PlansNASDAQ:GENEGenetic Technologies Ltd
09/08/202307:00GlobeNewswire Inc.Genetic Technologies Limited Announces Updated Investor PresentationNASDAQ:GENEGenetic Technologies Ltd
28/07/202307:00GlobeNewswire Inc.Quarterly Activities Update: Encouraging Growth for geneType Commercial Test VolumeNASDAQ:GENEGenetic Technologies Ltd
21/07/202307:00GlobeNewswire Inc.Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:GENEGenetic Technologies Ltd
23/05/202307:00GlobeNewswire Inc.GeneType featured on U.S. National TV to raise Breast Cancer AwarenessNASDAQ:GENEGenetic Technologies Ltd
10/05/202307:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GENEGenetic Technologies Ltd
 Showing the most relevant articles for your search:NASDAQ:GENE

Su Consulta Reciente

AMEX
XLV
Health Care Select Sector
COIN
BTCUSD
Bitcoin
NYSE
BAC
Bank of America
NYSE
CVX
Chevron
FX
EURMXN
Euro vs MXN
NYSE
MCD
McDonalds
NYSE
KO
Coca Cola
FX
USDMXN
US Dollar vs MXN
NASDAQ
GOOGL
Alphabet
USOTC
ADDYY
Adidas (QX)
AMEX
XLE
Energy Select Sector SPDR
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US500
US 500
COIN
SOLUSD
Solana
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados